Review of the Federal Bureau of Prisons' Pharmaceutical Drug Costs and Procurement
- NARA ID
- review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Source
- oig-doj
- Collection
- DOJ OIG — Federal Bureau of Prisons
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2020-02-20
- Slug
- doj-oig-review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Indexed
- 2026-04-27 05:04:10
More from DOJ OIG — Federal Bureau of Prisons
- Evaluation of the Federal Bureau of Prisons’ Policy Development Process
- Audit of the Federal Bureau of Prisons’ Perimeter Security Strategy and Efforts Related to the Contract Awarded to DeTekion Security Systems, Incorporated, to Update the Lethal/Non-Lethal Fence at Nine United States Penitentiaries
- Remote Inspection of Metropolitan Correctional Center Chicago
- Notification of Concerns Regarding the Federal Bureau of Prisons' Use of Temporary Secure Enclosures with Limited Space for Lengthy Time Periods
- Audit of the Federal Bureau of Prisons Annual Financial Statements Fiscal Year 2015
- Remote Inspection of Federal Correctional Complex Tucson
Browse all 158 documents in DOJ OIG — Federal Bureau of Prisons →
About the DOJ OIG — Federal Bureau of Prisons collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Federal Bureau of Prisons.